Explore the words cloud of the HBM4EU project. It provides you a very rough idea of what is the project "HBM4EU" about.
The following table provides information about the project.
Coordinator |
UMWELTBUNDESAMT
Organization address contact info |
Coordinator Country | Germany [DE] |
Project website | http://hbm4eu.eu |
Total cost | 74˙169˙889 € |
EC max contribution | 49˙933˙776 € (67%) |
Programme |
1. H2020-EU.3.1.2. (Preventing disease) |
Code Call | H2020-SC1-2016-RTD |
Funding Scheme | COFUND-EJP |
Starting year | 2017 |
Duration (year-month-day) | from 2017-01-01 to 2021-12-31 |
Take a look of project's partnership.
The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts and will communicate with policy makers to ensure that our results are exploited in the design of new chemicals policies and the evaluation of existing measures. Key objectives include: • Harmonizing procedures for human biomonitoring across 26 countries, to provide policy makers with comparable data on human internal exposure to chemicals and mixtures of chemicals at EU level; • Linking data on internal exposure to chemicals to aggregate external exposure and identifying exposure pathways and upstream sources. Information on exposure pathways is critical to the design of targeted policy measures to reduce exposure; • Generating scientific evidence on the causal links between human exposure to chemicals and negative health outcomes; and • Adapting chemical risk assessment methodologies to use human biomonitoring data and account for the contribution of multiple external exposure pathways to the total chemical body burden. We will achieve these objectives by harmonizing human biomonitoring initiatives in 26 countries, drawing on existing expertise and building new capacities. By establishing National Hubs in each country to coordinate activities, we will create a robust Human Biomonitoring Platform at European level. This initiative contributes directly to the improvement of health and well-being for all age groups, by investigating how exposure to chemicals affects the health of different groups, such as children, pregnant women, foetuses and workers. We will also investigate how factor such as behavior, lifestyle and socio-economic status influence internal exposure to chemicals across the EU population. This knowledge will support policy action to reduce chemical exposure and protect health.
Report on approaches to identify mixture health effects (UBRUN) | Documents, reports | 2020-03-25 16:16:45 |
2020 Programme of training activities, materials and capacity building mechanisms (RUMC) | Documents, reports | 2020-03-25 16:16:45 |
2nd review of training methods (RUMC) | Documents, reports | 2020-03-25 16:16:44 |
Report information needs from policy makers translated in terms of functionality of HBM mixture information | Documents, reports | 2020-03-25 16:16:44 |
Second report on biobank activities (KI) | Documents, reports | 2020-03-25 16:16:44 |
Second report on targeted new fieldwork and results | Documents, reports | 2020-03-25 16:16:44 |
2020 Strategy for the communication and dissemination of HBM4EU results | Documents, reports | 2020-03-25 16:16:44 |
Scoping documents for 2020 | Documents, reports | 2020-03-25 16:16:44 |
2019 Programme of training activities, materials and capacity building mechanisms (RUMC) | Documents, reports | 2020-03-25 16:16:44 |
1st Report on analytical results and new methods development (IPA) | Documents, reports | 2020-03-25 16:16:44 |
Report on estimation of relevant tissue and biological fluid doses of 1st set of priority compounds in the EU population using refined PBTK modeling | Documents, reports | 2020-03-25 16:16:44 |
Sustainability of HBM4EU in the future and related operational architecture concept: first report | Documents, reports | 2020-03-25 16:16:44 |
Revised set of key indicators (DOMG) | Documents, reports | 2020-03-25 16:16:44 |
Identified gaps for the establishment of AOPs and required studies | Documents, reports | 2020-03-25 16:16:44 |
2nd substance-group specific risk assessment | Documents, reports | 2020-03-25 16:16:44 |
1st update on the report on opportunities and obstacles of combining HBM and health studies, availability of health studies and administrative registers and guidelines | Documents, reports | 2020-03-25 16:16:44 |
2nd-priorisation-Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and sampling | Documents, reports | 2020-03-25 16:16:44 |
Report Outline and workplan for the joint survey on HBM mixtures (IRAS) | Documents, reports | 2020-03-25 16:16:44 |
Databases of candidate laboratories for the 2nd prioritization round of substances (ULPGC) | Documents, reports | 2020-03-25 16:16:44 |
2nd material for communication to participants, including informed consent | Documents, reports | 2020-03-25 16:16:44 |
1st Phased Action Plan for translation of HBM results into policy advise, measures and suggestions for further research at general level (UAntwerpen) | Documents, reports | 2020-03-25 16:16:44 |
Initial report on occupational studies | Documents, reports | 2020-03-25 16:16:44 |
Statistical Analysis Plan for each substance group for 1st set of substances (ISGlobal) | Documents, reports | 2020-03-25 16:16:42 |
1st Report on stakeholder consultation and mapping of needs | Documents, reports | 2020-03-25 16:16:42 |
HBM4EU website | Websites, patent fillings, videos etc. | 2020-03-25 16:16:42 |
Scoping paper on the development of an indicator on chemical exposure in the European population | Documents, reports | 2020-03-25 16:16:42 |
Review paper on PBTK/D models for the 1st set of priority compounds | Documents, reports | 2020-03-25 16:16:43 |
2019 Strategy for the communication and dissemination of HBM4EU results | Documents, reports | 2020-03-25 16:16:43 |
Report on ongoing activities and existing data and data gaps for the 2nd prioritised substances including a list of metadata that can be uploaded in IPCheM (FMUL) | Documents, reports | 2020-03-25 16:16:43 |
Inventory of available samples and data collected from existing cohorts and preliminary results on exposure-response associations for 1st list of priority substances | Documents, reports | 2020-03-25 16:16:43 |
Statistical Analysis Plan for each substance group for 2nd set of substances (ISGlobal) | Documents, reports | 2020-03-25 16:16:44 |
The Quality Assurance/Quality Control Scheme in HBM4EU project (IPASUM) | Documents, reports | 2020-03-25 16:16:42 |
List of biomarkers for the 1st set of prioritized substances (UGR) | Documents, reports | 2020-03-25 16:16:43 |
Report real-life exposure profiles from re-analysis of existing HBM mixture data | Documents, reports | 2020-03-25 16:16:43 |
Report on biological half-lives of 1st set of priority compounds | Documents, reports | 2020-03-25 16:16:42 |
Report on the optimal methodology for exposure reconstruction from HBM data | Documents, reports | 2020-03-25 16:16:43 |
2017 Strategy for the communication and dissemination of HBM4EU results | Documents, reports | 2020-03-25 16:16:43 |
Report on ongoing activities and existing data and data gaps for the 1st prioritised substances including a list of metadata that can be uploaded in IPCheM (FMUL) | Documents, reports | 2020-03-25 16:16:43 |
Prioritised list of biomarkers, matrices and analytical methods for the 1st prioritization round of substances | Documents, reports | 2020-03-25 16:16:43 |
Report on available biomarkers of effect of proven utility in human epidemiological studies for the 1st set of prioritised substances (UGR) | Documents, reports | 2020-03-25 16:16:42 |
Legal and Ethics Policy document (UCPH) | Documents, reports | 2020-03-25 16:16:43 |
Templates for the submission of urgent requests for new information, one for EU policy makers and one for national policy makers (ANSES) | Documents, reports | 2020-03-25 16:16:43 |
Prioritisation strategy and criteria (ANSES) | Documents, reports | 2020-03-25 16:16:42 |
Report on results of the selected biomarker of effect (UGR) | Documents, reports | 2020-03-25 16:16:42 |
List of criteria for selecting cohort studies | Documents, reports | 2020-03-25 16:16:42 |
Strategy and SOPs for human sample exchange, including ethical demands (IBMT) | Documents, reports | 2020-03-25 16:16:42 |
Second list of prioritised substances and proposed CGLs for 2019-2021 (ANSES) | Documents, reports | 2020-03-25 16:16:42 |
First report on targeted new fieldwork study results | Documents, reports | 2020-03-25 16:16:43 |
Description of national programmes | Documents, reports | 2020-03-25 16:16:43 |
Report on opportunities and obstacles of combining HBM and health studies, availability of health studies and administrative registers and guidelines | Documents, reports | 2020-03-25 16:16:43 |
Databases of candidate laboratories for the 1st prioritization round of substances (ULPGC) | Documents, reports | 2020-03-25 16:16:42 |
1st review of training methods (RUMC) | Documents, reports | 2020-03-25 16:16:44 |
Criteria for prioritisation of biomarkers of effect (UGR) | Documents, reports | 2020-03-25 16:16:42 |
Initial report on strategies adopted to align studies across Europe and preliminary results | Documents, reports | 2020-03-25 16:16:43 |
2018 Strategy for the communication and dissemination of HBM4EU results | Documents, reports | 2020-03-25 16:16:43 |
Establishment of Stakeholder Forum and Advisory Board | Documents, reports | 2020-03-25 16:16:42 |
1st substance-group specific derivation of EU-wide health based guidance values | Documents, reports | 2020-03-25 16:16:42 |
First set of key indicators (LNE Department) | Documents, reports | 2020-03-25 16:16:42 |
Workflows for screening emerging chemicals (INRA) | Documents, reports | 2020-03-25 16:16:43 |
1st annual list of exposure distributions and/or EU-wide reference values | Documents, reports | 2020-03-25 16:16:43 |
Report on workshop about opportunities and obstracles for linking HBM and health studies | Documents, reports | 2020-03-25 16:16:43 |
2018 Programme of training activities, materials and capacity building mechanisms (RUMC) | Documents, reports | 2020-03-25 16:16:43 |
1st Report on the content and use of the online library | Documents, reports | 2020-03-25 16:16:43 |
1st substance-group specific risk assessment | Documents, reports | 2020-03-25 16:16:42 |
Scoping documents for 2019 | Documents, reports | 2020-03-25 16:16:44 |
Prioritized list of known emerging chemicals (IRAS) | Documents, reports | 2020-03-25 16:16:42 |
Establishment of Governing Board | Documents, reports | 2020-03-25 16:16:42 |
Criteria for prioritisation of biomarkers, matrices and analytical methods (ANSP) | Documents, reports | 2020-03-25 16:16:43 |
First report on biobank activities (KI) | Documents, reports | 2020-03-25 16:16:43 |
Prioritised list of biomarkers, matrices and analytical methods for the 2nd prioritization round of substances | Documents, reports | 2020-03-25 16:16:43 |
1st-priorisation-Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and sampling | Documents, reports | 2020-03-25 16:16:43 |
1st material for communication to participants, including informed consent | Documents, reports | 2020-03-25 16:16:43 |
Data management plan | Documents, reports | 2020-03-25 16:16:43 |
Template for AOP update report for selected priority substances | Documents, reports | 2020-03-25 16:16:43 |
Scoping documents for 2018 | Documents, reports | 2020-03-25 16:16:42 |
First Report on national needs, objectives of a long-term HBM4EU, inventory of funding mechanisms and recommendations for a sustainable HBM initiative in Europe and its organisation | Documents, reports | 2020-03-25 16:16:43 |
Selection criteria and inventory of effect biomarkers for the 2nd set of substances (UGR) | Documents, reports | 2020-03-13 11:15:10 |
Take a look to the deliverables list in detail: detailed list of HBM4EU deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2019 |
Marylène Rugard, Xavier Coumoul, Jean-Charles Carvaillo, Robert Barouki, Karine Audouze Deciphering Adverse Outcome Pathway Network Linked to Bisphenol F Using Text Mining and Systems Toxicology Approaches published pages: 32-40, ISSN: 1096-6080, DOI: 10.1093/toxsci/kfz214 |
Toxicological Sciences 173/1 | 2020-03-25 |
2020 |
Elina Drakvik, Rolf Altenburger, Yasunobu Aoki, Thomas Backhaus, Tina Bahadori, Robert Barouki, Werner Brack, Mark T.D. Cronin, Barbara Demeneix, Susanne Hougaard Bennekou, Jacob van Klaveren, Carsten Kneuer, Marike Kolossa-Gehring, Erik Lebret, Leo Posthuma, Lena Reiber, Cynthia Rider, Joëlle Rüegg, Giuseppe Testa, Bart van der Burg, Hilko van der Voet, A. Michael Warhurst, Bob van de Water, Ku Statement on advancing the assessment of chemical mixtures and their risks for human health and the environment published pages: 105267, ISSN: 0160-4120, DOI: 10.1016/j.envint.2019.105267 |
Environment International 134 | 2020-03-25 |
2019 |
Loreta Strumylaite, Rima Kregzdyte, Algirdas Bogusevicius, Lina Poskiene, Dale Baranauskiene, Darius Pranys Cadmium Exposure and Risk of Breast Cancer by Histological and Tumor Receptor Subtype in White Caucasian Women: A Hospital-Based Case-Control Study published pages: 3029, ISSN: 1422-0067, DOI: 10.3390/ijms20123029 |
International Journal of Molecular Sciences 20/12 | 2020-03-25 |
2019 |
Jean-Charles Carvaillo, Robert Barouki, Xavier Coumoul, Karine Audouze Linking Bisphenol S to Adverse Outcome Pathways Using a Combined Text Mining and Systems Biology Approach published pages: 47005, ISSN: 0091-6765, DOI: 10.1289/ehp4200 |
Environmental Health Perspectives 127/4 | 2020-03-25 |
2017 |
Tamar Berman, Rebecca Goldsmith, Hagai Levine, Itamar Grotto Human biomonitoring in Israel: Recent results and lessons learned published pages: 6-12, ISSN: 1438-4639, DOI: 10.1016/j.ijheh.2016.09.008 |
International Journal of Hygiene and Environmental Health 220/2 | 2020-03-25 |
2019 |
Michiel Bastiaensen, Govindan Malarvannan, Frederic Been, Shanshan Yin, Yiming Yao, Johan Huygh, Katrien Clotman, Tom Schepens, Philippe G. Jorens, Adrian Covaci Metabolites of phosphate flame retardants and alternative plasticizers in urine from intensive care patients published pages: 590-596, ISSN: 0045-6535, DOI: 10.1016/J.CHEMOSPHERE.2019.05.280 |
Chemosphere 233 | 2020-03-25 |
2018 |
Bilal B Mughal, Jean-Baptiste Fini, Barbara A Demeneix Thyroid-disrupting chemicals and brain development: an update published pages: R160-R186, ISSN: 2049-3614, DOI: 10.1530/EC-18-0029 |
Endocrine Connections 7/4 | 2020-03-25 |
2019 |
Tiina Santonen, Alessandro Alimonti, Beatrice Bocca, Radu Corneliu Duca, Karen S. Galea, Lode Godderis, Thomas Göen, Bruno Gomes, Ogier Hanser, Ivo Iavicoli, Beata Janasik, Kate Jones, Mirja Kiilunen, Holger M. Koch, Elizabeth Leese, Veruscka Leso, Henriqueta Louro, Sophie Ndaw, Simo P. Porras, Alain Robert, Flavia Ruggieri, Paul T.J. Scheepers, Maria J. Silva, Susana Viegas, Wojciech Wasowicz, A Setting up a collaborative European human biological monitoring study on occupational exposure to hexavalent chromium published pages: 108583, ISSN: 0013-9351, DOI: 10.1016/j.envres.2019.108583 |
Environmental Research 177 | 2020-03-25 |
2019 |
Kirsten A. Baken, Nathalie Lambrechts, Sylvie Remy, Vicente Mustieles, Andrea RodrÃguez-Carrillo, Christiana M. Neophytou, Nicolas Olea, Greet Schoeters A strategy to validate a selection of human effect biomarkers using adverse outcome pathways: Proof of concept for phthalates and reproductive effects published pages: 235-256, ISSN: 0013-9351, DOI: 10.1016/j.envres.2019.05.013 |
Environmental Research 175 | 2020-03-25 |
2019 |
Henriqueta Louro, Milla Heinälä, Jos Bessems, Jurgen Buekers, Theo Vermeire, Marjolijn Woutersen, Jacqueline van Engelen, Teresa Borges, Christophe Rousselle, Eva Ougier, Paula Alvito, Carla Martins, Ricardo Assunção, Maria João Silva, Anjoeka Pronk, Bernice Schaddelee-Scholten, Maria Del Carmen Gonzalez, Mercedes de Alba, Argelia Castaño, Susana Viegas, Tatjana Humar-Juric, Lijana Kononenko Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future published pages: 727-737, ISSN: 1438-4639, DOI: 10.1016/j.ijheh.2019.05.009 |
International Journal of Hygiene and Environmental Health 222/5 | 2020-03-25 |
2018 |
Stephanie K. Bopp, Robert Barouki, Werner Brack, Silvia Dalla Costa, Jean-Lou C.M. Dorne, Paula E. Drakvik, Michael Faust, Tuomo K. Karjalainen, Stylianos Kephalopoulos, Jacob van Klaveren, Marike Kolossa-Gehring, Andreas Kortenkamp, Erik Lebret, Teresa Lettieri, Sofie Nørager, Joëlle Rüegg, Jose V. Tarazona, Xenia Trier, Bob van de Water, Jos van Gils, Åke Bergman Current EU research activities on combined exposure to multiple chemicals published pages: 544-562, ISSN: 0160-4120, DOI: 10.1016/j.envint.2018.07.037 |
Environment International 120 | 2020-03-25 |
2019 |
Dimosthenis A. Sarigiannis, Spyros Karakitsios, Elena Dominguez-Romero, Krystalia Papadaki, Celine Brochot, Vikas Kumar, Marta Schumacher, Moustapha Sy, Hans Mielke, Mathias Greiner, Marcel Mengelers, Martin Scheringer Physiology-based toxicokinetic modelling in the frame of the European Human Biomonitoring Initiative published pages: 216-230, ISSN: 0013-9351, DOI: 10.1016/j.envres.2019.01.045 |
Environmental Research 172 | 2020-03-25 |
2017 |
Catherine Ganzleben, Jean-Philippe Antignac, Robert Barouki, Argelia Castaño, Ulrike Fiddicke, Jana Klánová, Erik Lebret, Nicolas Olea, Dimosthenis Sarigiannis, Greet R. Schoeters, Ovnair Sepai, Hanna Tolonen, Marike Kolossa-Gehring Human biomonitoring as a tool to support chemicals regulation in the European Union published pages: 94-97, ISSN: 1438-4639, DOI: 10.1016/j.ijheh.2017.01.007 |
International Journal of Hygiene and Environmental Health 220/2 | 2020-03-25 |
2019 |
Lola Bajard, Lisa Melymuk, Ludek Blaha Prioritization of hazards of novel flame retardants using the mechanistic toxicology information from ToxCast and Adverse Outcome Pathways published pages: , ISSN: 2190-4707, DOI: 10.1186/s12302-019-0195-z |
Environmental Sciences Europe 31/1 | 2020-03-25 |
2018 |
Jurgen Buekers, Madlen David, Gudrun Koppen, Jos Bessems, Martin Scheringer, Erik Lebret, Denis Sarigiannis, Marike Kolossa-Gehring, Marika Berglund, Greet Schoeters, Xenia Trier Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population published pages: 2085, ISSN: 1660-4601, DOI: 10.3390/ijerph15102085 |
International Journal of Environmental Research and Public Health 15/10 | 2020-03-25 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HBM4EU" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "HBM4EU" are provided by the European Opendata Portal: CORDIS opendata.